Despite the large amount of data demonstrating the occurrence of a functional impairment of stem cells upon aging, there is a lack of knowledge on molecular mechanisms to explain, prevent or restore this functional decline. Epigenetic alterations do not irreversibly change the DNA sequence and can be considered a drug target.

My research explores novel epigenetic approaches to therapeutically rejuvenate function of aged somatic stem cells.